The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
about
Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expressionc-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cellsTranscription factor Egr-1 regulates glomerular mesangial cell proliferationRegulation of vascular smooth muscle cell proliferation by plasma membrane Ca(2+)-ATPaseEnhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol.Myb targeted therapeutics for the treatment of human malignancies.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotideRescue of B cells from apoptosis by immune stimulatory CpG DNA.Silica nanoparticles as a delivery system for nucleic acid-based reagents.Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.Biophysical and biological properties of quadruplex oligodeoxyribonucleotidesTargeting c-Myb expression in human disease.Drosophila myb is required for the G2/M transition and maintenance of diploidyAccessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a targetIntratumoural administration of dendritic cells: hostile environment and help by gene therapy.Antisense approaches for inhibiting respiratory syncytial virus.Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout micePrevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1).Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines.Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerAdvances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.Therapeutic prospect of Syk inhibitors.Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides.Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond.Potent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1.Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury.Distinct functions of Gq and G11 proteins in coupling alpha1-adrenoreceptors to Ca2+ release and Ca2+ entry in rat portal vein myocytes.Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide.Specific inhibition of transforming growth factor-beta2 expression in human osteoblast cells by antisense phosphorothioate oligonucleotides.Target site search and effective inhibition of leukaemic cell growth by a covalently closed multiple anti-sense oligonucleotide to c-myb.Current status of gene therapy in gastroenterology.RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.Temperature and salt dependence of higher order structure formation by antisense c-myc and c-myb phosphorothioate oligodeoxyribonucleotides containing tetraguanylate tracts.
P2860
Q28367828-57513E80-55A2-4A3C-81A2-5CB533AC422FQ28568750-1E0F73CB-83FC-4277-B0B2-C84C7C5F2D2DQ28573049-34749F67-CB12-4FED-99FF-39CEB8A71D09Q28577927-C388A106-C19D-4C4E-A0E2-5F787CF27920Q32035441-F5327DF9-B615-4C8F-82DB-869981841B08Q33667372-2EE6C2C3-B411-4B1D-856E-6A8B7B4B77E5Q33978043-E2F784B3-99B6-4B44-ADA6-77D866B5867CQ34005396-02CFA17D-108C-411A-AF6E-03C0E3B1826CQ34080775-7368B798-027E-4FF7-ACA4-30DA0C632879Q34774748-C917C65E-7CBE-4269-9760-56A72DDD26C4Q34966734-F87E887B-B4DA-4501-A424-0B5A3F14BF4DQ35095153-BFEE256C-FD53-486B-A17C-E3D2EA2AE909Q35194105-E2A58984-F734-480D-9F02-F3833BB8E652Q35899878-957E7D51-B26F-451F-9808-E1C5C2B5B2B2Q36040788-18F81CA9-E5A7-41AD-B076-8DD58485B860Q36065956-212DD001-0D76-49E0-93FA-DACFEA8A6BCEQ36108131-095FBD97-E120-4D60-ACE4-D78F222E1248Q36135764-681DC49A-A3ED-4925-B179-EBBE88066801Q36304199-0E359542-EED0-4C1D-9300-D57BCA3C9B32Q36437573-DD0A4D99-FD3C-4A49-A9BF-748019E44FC6Q36561742-F364C07D-7063-40CA-BFA2-1FA5CB9417BDQ36616430-AE014E59-3556-486B-A636-4AB89B2BD038Q36689270-91F105C5-B94D-4691-B2DA-9304FA531556Q36918516-C2134062-EA79-43C7-8B41-4BF6CBB90924Q37210126-8BC7C294-354C-4195-B775-BDB87EA2D726Q37277677-935020B9-4B73-4669-9043-E1E1B2271835Q37321859-398E02CE-69EF-4F84-B9C7-C88638EE3D92Q37357738-314E31BC-EDAE-4A9C-81AF-8B3E996784B7Q37577893-0EC66F6A-1EFF-4D2F-80DF-6E3C1B736B04Q38297014-77FF4BBB-2996-44FE-A359-B6FB27CA3E3EQ38303734-1CB0EC77-1320-4F04-AC1E-77F7C8FA5080Q38315545-24A8D722-2C0C-449B-8A11-904906C50340Q38332355-571878B6-7575-4691-96EC-8F17FB7951BBQ38348336-A5D0950D-C012-4D44-B791-0E08261E2EE6Q38358127-4511A103-456A-41B7-A7D9-9AB05E04939EQ38525046-72B0735D-12A4-42DA-BFB4-372169EEB816Q38526597-2A4627EC-9CD6-4522-8788-0FA37E565466Q38634850-68A85B19-FA51-4F69-917E-28E543DDA47CQ39719200-BF3CD3C2-6B14-48F1-8E48-680812B04BD5Q39719580-DDC10397-29BE-489E-91E2-F2199A133B79
P2860
The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The antiproliferative activity ...... d by a nonantisense mechanism.
@ast
The antiproliferative activity ...... d by a nonantisense mechanism.
@en
The antiproliferative activity ...... d by a nonantisense mechanism.
@nl
type
label
The antiproliferative activity ...... d by a nonantisense mechanism.
@ast
The antiproliferative activity ...... d by a nonantisense mechanism.
@en
The antiproliferative activity ...... d by a nonantisense mechanism.
@nl
prefLabel
The antiproliferative activity ...... d by a nonantisense mechanism.
@ast
The antiproliferative activity ...... d by a nonantisense mechanism.
@en
The antiproliferative activity ...... d by a nonantisense mechanism.
@nl
P2093
P2860
P356
P1476
The antiproliferative activity ...... d by a nonantisense mechanism.
@en
P2093
Bayewitch LA
Burgess TL
Herrera CJ
P2860
P304
P356
10.1073/PNAS.92.9.4051
P407
P577
1995-04-01T00:00:00Z